Granulomatous hepatitis: a complication of B.C.G. immunotherapy

Tumor doubling time: a selection factor for pulmonary resection of metastatic melanoma.

Journal of surgical oncology·1999

Active immunotherapy with allogeneic tumor cell vaccines: present status.

Seminars in oncology·1998

Anti-tyrosinase-related protein-2 immune response in vitiligo patients and melanoma patients receiving active-specific immunotherapy.

The Journal of investigative dermatology·1998

Universal application of intraoperative lymphatic mapping and sentinel lymphadenectomy in solid neoplasms.

The cancer journal from Scientific American·1998

Enhancement of complement-dependent cytotoxicity by polyvalent melanoma cell vaccine (CancerVax): correlation with survival.

Annals of surgical oncology·1998

Antibody responses to melanoma/melanocyte autoantigens in melanoma patients.

The Journal of investigative dermatology·1998

Rezpegaldesleukin treatment of moderate-to-severe atopic dermatitis (REZOLVE-AD): final results from the 16-week induction period of an international, double-blind, placebo-controlled, randomised phase 2b study.

Lancet (London, England)·2026

Robotic-arm-assisted versus conventional total knee replacement (RACER-Knee): a pragmatic, multicentre, participant-masked and assessor-masked, superiority, randomised controlled trial.

Lancet (London, England)·2026

Risk of transmission of amyloid β pathology via transfused blood products.

Lancet (London, England)·2026

Liver resection after atezolizumab and bevacizumab versus maintenance therapy for locally advanced hepatocellular carcinoma (TALENTOP): a multicentre, open-label, randomised, phase 3 trial.

Lancet (London, England)·2026

Increased anergic B cells and decreased antibody-secreting cells during romiplostim treatment in patients with immune thrombocytopenia.

British journal of haematology·2026

Passive Transfer of Hepatitis B Core Antibody Following Intravenous Ig Administration: Clinical Implications and Considerations.

ACR open rheumatology·2026

Investigating the role of serum IL-6 in predicting outcomes of b-cell depleting therapy in multiple sclerosis: a retrospective cohort study.

BMC neurology·2026

iPSC-derived neurospheres: A cellular platform for Tau and Alzheimer's disease immunotherapy.

Advances in immunology·2026

Expanding the therapeutic landscape of Still's disease: the emerging role of JAK inhibitors.

Expert opinion on pharmacotherapy·2026

Related Experiment Videos

Granulomatous hepatitis: a complication of B.C.G. immunotherapy

Related Concept Videos

Tumor doubling time: a selection factor for pulmonary resection of metastatic melanoma.

Active immunotherapy with allogeneic tumor cell vaccines: present status.

Anti-tyrosinase-related protein-2 immune response in vitiligo patients and melanoma patients receiving active-specific immunotherapy.

Universal application of intraoperative lymphatic mapping and sentinel lymphadenectomy in solid neoplasms.

Enhancement of complement-dependent cytotoxicity by polyvalent melanoma cell vaccine (CancerVax): correlation with survival.

Antibody responses to melanoma/melanocyte autoantigens in melanoma patients.

Rezpegaldesleukin treatment of moderate-to-severe atopic dermatitis (REZOLVE-AD): final results from the 16-week induction period of an international, double-blind, placebo-controlled, randomised phase 2b study.

Robotic-arm-assisted versus conventional total knee replacement (RACER-Knee): a pragmatic, multicentre, participant-masked and assessor-masked, superiority, randomised controlled trial.

Risk of transmission of amyloid β pathology via transfused blood products.

Liver resection after atezolizumab and bevacizumab versus maintenance therapy for locally advanced hepatocellular carcinoma (TALENTOP): a multicentre, open-label, randomised, phase 3 trial.

Increased anergic B cells and decreased antibody-secreting cells during romiplostim treatment in patients with immune thrombocytopenia.

Passive Transfer of Hepatitis B Core Antibody Following Intravenous Ig Administration: Clinical Implications and Considerations.

Investigating the role of serum IL-6 in predicting outcomes of b-cell depleting therapy in multiple sclerosis: a retrospective cohort study.

iPSC-derived neurospheres: A cellular platform for Tau and Alzheimer's disease immunotherapy.

Expanding the therapeutic landscape of Still's disease: the emerging role of JAK inhibitors.

Related Experiment Videos

Granulomatous hepatitis: a complication of B.C.G. immunotherapy

Related Concept Videos

Related Articles